首页> 外国专利> Method for treating malignant pleural effusion

Method for treating malignant pleural effusion

机译：恶性胸腔积液的治疗方法

页面导航

摘要
著录项
相似文献

摘要

The present invention is directed to a method for treating malignant pleural effusion comprising administering a first herbal medicine composition to a subject in need; wherein the first chinese herbal medicine is an extract of a first mixture comprising Poria, Grifola, Rhizoma Atractylodis, Rhizoma Alismatis, Semen Lepidii, Rhizoma Atractylodis Macrocephalae, Herba Ephedrae, Fructus Jujubae, Fructus Crataegi, dried Langan, Radix Stephaniae Tetrandrae, and Rhizoma Gastrodiae; Ginseng powder; and a second mixture comprising Radix Kansui, Euphorbia pekinensis, Flos Genkwa.

机译：本发明涉及一种用于治疗恶性胸腔积液的方法，该方法包括将第一草药组合物施用于需要的受试者。其中所述第一中草药是第一混合物的提取物，所述第一混合物包括Po，白花菜，白术，白术，Se子，白术，麻黄，大枣，大果，干燥的兰根，基数 Stephaniae Tetrandrae和 Rhizoma Gastrodiae; 人参粉;以及第二种混合物，其包含甘草，大戟，花药根。 展开▼

著录项

公开/公告号US10258663B2

专利类型

公开/公告日2019-04-16

原文格式PDF

申请/专利权人 CHEN-YU LEE;
展开▼

申请/专利号US201715668830

发明设计人 CHEN-YU LEE;TSAI-WANG HUANG;YAN-CHIH LIAO;
展开▼

申请日2017-08-04

分类号A61K36;A61K36/8988;A61K36/076;A61K36/07;A61K36/284;A61K36/884;A61K36/31;A61K36/17;A61K36/734;A61K36/77;A61K36/71;A61K36/258;A61K36/47;A61K36/83;A61K36/88;A61K35/32;

国家 US

入库时间 2022-08-21 12:15:51

相似文献

专利

外文文献

中文文献

1. 一种用于治疗恶性胸腔积液的中药组合物 [P] . 中国专利： CN111939239B . 2022.02.01

2. 用于治疗恶性胸腔积液的新颖苯磺酰胺组合物 [P] . 中国专利： CN109475517B . 2021.06.29

3. METHOD FOR TREATING MALIGNANT PLEURAL EFFUSION [P] . 美国专利： US2019038698A1 . 2019-02-07

机译：治疗恶性胸腔积液的方法

4. MOLECULAR MARKER FOR THE EARLY DETECTION OF MALIGNANT PLEURAL MESOTHELIOMA AND THE METHODS OF ITS EXPRESSION ANALYSIS USING BLOOD AND PLEURAL EFFUSION SAMPLES [P] . 美国专利： US2014363832A1 . 2014-12-11

机译：早期检测恶性胸膜间皮瘤的分子标志物及其血，胸腔积液样品的表达分析方法

5. Method for the diagnosis of malignant pleural effusion by determining calprotectin concentration in pleural fluid. [P] . ES2402457B2 . 2014-01-20

机译：通过确定胸水中钙卫蛋白的浓度来诊断恶性胸腔积液的方法。

1. Effect of intrapleural endostatin and mannatide infusion on malignant molecule expression in pleural fluid of malignant pleural effusion [J] . Juan Kang 海南医科大学学报（英文版） . 2017,第002期

2. Effect of intrapleural endostatin and mannatide infusion on malignant molecule expression in pleural fluid of malignant pleural effusion [J] . Juan Kang 海南医科大学学报(英文版) . 2017,第002期

3. Comparison of intra-pleural injection efficacy between Endostar and Bevacizumab combined with pemetrexed/cisplatin for the treatment of malignant pleural effusion in patients with epidermal growth factor receptor-/anaplastic lymphoma kinase-lung adenocarci [J] . Yi Cheng, Nan Huang, Kai Qin, 肿瘤学与转化医学（英文） . 2019,第002期

4. Effect of percutaneous radiofrequency ablation after thoracoscopic pleurodesis for treating non-small cell lung cancer patients with malignant pleural effusion and/or pleural dissemination [J] . Liu Baodong, Liu Lei, Hu Mu, Thoracic cancer. . 2016,第5期

5. Survival Difference in Patients with Malignant Pleural Effusions Treated with Pleural Catheter or Talc Pleurodesis [J] . Liou Douglas Z., Serna-Gallegos Derek, Chan Joshua L., The American surgeon. . 2016,第10期

6. Effect of percutaneous radiofrequency ablation after thoracoscopic pleurodesis for treating non‐small cell lung cancer patients with malignant pleural effusion and/or pleural dissemination [J] . Liu Baodong, Liu Lei, Hu Mu, Thoracic cancer. . 2016,第5期

7. Intra-pleural Cavity hot Saline Perfusion and Intra-pleural Cavity cis-DDPInjection in the Treatment of malignant Pleural Effusion,the Preliminary Observation [C] . The 3rd Asian congress on hyperthermic oncology and the 9th Chineses symposium on hyperthermic oncology . 2002

8. The usefulness of pleural fluid presepsin, C-reactive protein, and procalcitonin in distinguishing different causes of pleural effusions [D] . 渡邊直樹 2019

9. Discriminating Tuberculous Pleural Effusion from Malignant Pleural Effusion Based on Routine Pleural Fluid Biomarkers Using Mathematical Methods [O] . Reza Darooei, Ghazal Sanadgol, Arman Gh-Nataj, 2017

10. Effect of percutaneous radiofrequency ablation after thoracoscopic pleurodesis for treating non‐small cell lung cancer patients with malignant pleural effusion and/or pleural dissemination [O] . Baodong Liu, Lei Liu, Mu Hu, 2016

1. Clinical Value of Vascular Endothelial Growth Factor Combined with Interferon-γ in Diagnosing Malignant Pleural Effusion and Tuberculous Pleural Effusion [J] . XUE Keying ,XIONG Shengdao ,XIONG Weining . 华中科技大学学报（医学）（英德文版） . 2007,第005期

2. Study on the Correlation between Syndrome Differentiation of Malignant Pleural Effusion Treated by External Treatment of Traditional Chinese Medicine and Immunohistochemistry of Biopsy Tissue Based on Medical Video-assisted Thoracoscope [J] . De-Min Li ,Xin-Yang Shu ,Dao-Wen Yang . TMR肿瘤进展 . 2021,第6期

3. 中药口服汤剂联合顺铂胸腔灌注治疗肺癌恶性胸腔积液临床疗效的Meta分析 [C] . JIN Zhi-chao ,金志超 ,SHI Zhan . 第九届全国中医药博士生学术论坛 . 2018

4. 兔VX2恶性胸腔积液模型的建立及凝血醇、滑石粉对恶性胸腔积液治疗机制的研究 [A] . 张磊 . 2013